KCM
CLLS

Kennedy Capital Management’s Cellectis CLLS Stock Holding History

Kennedy Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-46,496
Closed -$586K – 620
2021
Q3 		$586K Buy
46,496
+778
+2% +$10.8K 0.01% 566
2021
Q2 		$707K Sell
45,718
-70,841
-61% -$1.19M 0.02% 549
2021
Q1 		$2.36M Sell
116,559
-1,194
-1% -$29.5K 0.05% 499
2020
Q4 		$3.19M Sell
117,753
-761
-0.6% -$17.1K 0.07% 436
2020
Q3 		$2.19M Sell
118,514
-82,550
-41% -$1.46M 0.06% 479
2020
Q2 		$3.58M Sell
201,064
-54,291
-21% -$826K 0.1% 378
2020
Q1 		$2.35M Buy
+255,355
New +$3.81M 0.09% 421

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Kennedy Capital Management's CLLS Position: Q4 2021 in Review

Kennedy Capital Management sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 46,496 shares — an estimated $586K sold.

Kennedy Capital Management first reported a position in CLLS in Q1 2020 and held it in 7 quarters. The position peaked at $3.58M in Q2 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Kennedy Capital Management reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Kennedy Capital Management sold 46,496 Cellectis shares in Q4 2021, an estimated $586K.
  • Kennedy Capital Management first reported a position in Cellectis in Q1 2020 and held it in 7 quarters.
  • Kennedy Capital Management's Cellectis position peaked at $3.58M in Q2 2020.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Kennedy Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.